These Were the 5 Top Genetics Stocks of 2020
Genetics is a high tech, research-intensive business. Between the complexity of the science and the demands of the clinical trials and regulatory approval process, it's also quite risky -- but the rewards can be immense.
Many genetics companies spent the year working on the projects that might become their first sources of revenue. The market reacted to their every peep, and there's a good chance that several of these stocks will have another bumper crop year in 2021.
Image source: Getty Images.
Source Fool.com
